Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DDB1 | Q16531 | 1/20 | 0.69 |
| ▸ | CRBN | Q96SW2 | 1/20 | 0.69 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.68 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.49 |
| ▸ | MEN1 | O00255 | 4/20 | 0.49 |
| ▸ | GAA | P10253 | 3/20 | 0.47 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.46 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.46 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.46 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.46 |
| ▸ | F2 | P00734 | 1/20 | 0.45 |
| ▸ | PLG | P00747 | 1/20 | 0.45 |
| ▸ | ELANE | P08246 | 1/20 | 0.45 |
| ▸ | CTSG | P08311 | 1/20 | 0.45 |
| ▸ | CMA1 | P23946 | 1/20 | 0.45 |
| ▸ | CTRC | Q99895 | 1/20 | 0.45 |
| ▸ | POLB | P06746 | 1/20 | 0.45 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.45 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.45 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9850086 | 1.00 | DDB1 (0.69) | DDB1CRBNEPHX2KMT2AMEN1 | |
| SCHEMBL9850110 | 0.98 | DDB1 (0.67) | DDB1CRBNEPHX2KMT2AMEN1 | |
| SCHEMBL2001787 | 0.90 | ENPP2 (0.57) | DDB1CRBNEPHX2KMT2AMEN1 | |
| SCHEMBL10649531 | 0.84 | EPHX2 (0.62) | DDB1CRBNEPHX2KMT2AMEN1 | |
| SCHEMBL9164640 | 0.83 | EPHX2 (0.49) | DDB1CRBNEPHX2KMT2AMEN1 | |
| SCHEMBL6827489 | 0.81 | DDB1 (1.00) | DDB1CRBNEPHX2KMT2AMEN1 | |
| SCHEMBL22144492 | 0.81 | EPHX2 (0.47) | DDB1CRBNEPHX2KMT2AMEN1 | |
| SCHEMBL28757730 | 0.81 | EPHX2 (0.47) | DDB1CRBNEPHX2GAAHDAC2 | |
| SCHEMBL20189142 | 0.81 | EPHX2 (0.47) | DDB1CRBNEPHX2KMT2AMEN1 | |
| SCHEMBL8009140 | 0.81 | EPHX2 (0.47) | DDB1CRBNEPHX2KMT2AMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 186 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116514646-A | Preparation method of phenylpyruvic acid | 浙江昂利泰制药有限公司 | 2023-08-01 | — | — | CN | claimed |
| CN-114315619-B | Synthesis method of dimethoxy dopa | 山东泓瑞医药科技股份公司 | 2023-03-24 | — | — | CN | claimed |
| CN-114315619-A | Synthetic method of 3- (3, 4-dimethoxyphenyl) -L-alanine | 山东泓瑞医药科技股份公司 | 2022-04-12 | — | — | CN | claimed |
| EP-3716966-A2 | ALPHA KETO ACID COMPOSITIONS FOR TREATING HYPO-ALBUMINEMIA | Hull, Edgar, L., Jr. (US) | 2020-10-07 | — | — | EP | claimed |
| US-20200281881-A1 | Alpha Keto Acid Compositions for Treating Hypo-Albuminemia | Hull, Jr., Edgar L. (US) | 2020-09-10 | — | — | US | claimed |
| US-20080241896-A1 | PROCESS FOR PRODUCTION OF OPTICALLY ACTIVE HYDROXYMETHYL-SUBSTITUTED PHENYLALANINE | AJINOMOTO CO., INC. (JP) | 2008-10-02 | — | — | US | claimed |
| CN-100407923-C | Sterilization disinfectant and application thereof | NANJING UNIVERSITY OF TECHNOLOGY (CN) | 2008-08-06 | — | — | CN | claimed |
| EP-1867730-A1 | PROCESS FOR PRODUCTION OF OPTICALLY ACTIVE HYDROXYMETHYL -SUBSTITUTED PHENYLALANINE | Ajinomoto Co., Inc. (JP) | 2007-12-19 | — | — | EP | claimed |
| EP-1827434-A2 | QUINOLINES AND QUINAZOLINE ANALOGS AND THEIR USE AS MEDICAMENTS FOR TREATING CANCER | Amgen Inc. (US) | 2007-09-05 | — | — | EP | claimed |
| CN-1788564-A | Sterilization disinfectant and application thereof | NANJING UNIVERSITY OF TECHNOLOGY (CN) | 2006-06-21 | — | — | CN | claimed |
| WO-2006060318-A2 | QUINOLINES AND QUINAZOLINE ANALOGS AND THEIR USE AS MEDICAMENTS FOR TREATING CANCER | AMGEN INC. (US) | 2006-06-08 | — | — | WO | claimed |
| EP-0159866-B1 | PROCESS FOR PRODUCTION OF L-AMINO ACIDS | DENKI KAGAKU KOGYO KABUSHIKI KAISHA (JP) | 1991-04-03 | — | — | EP | claimed |
| JP-6100543-A | — | — | None | — | — | JP | disclosed |
| EP-4686757-A1 | INHIBITORS OF EXPRESSION AND/OR FUNCTION | e-therapeutics PLC (GB) | 2026-02-04 | — | — | EP | disclosed |
| US-20250228865-A1 | COMPOUNDS FOR ENHANCING READ THROUGH OF GENES CONTAINING PREMATURE TERMINATION CODONS AND METHODS FOR MAKING AND USING THE SAME | SANOFI US SERVICES INC. (US) | 2025-07-17 | — | — | US | disclosed |
| EP-4532487-A1 | COMPOUNDS FOR ENHANCING READ THROUGH OF GENES CONTAINING PREMATURE TERMINATION CODONS AND METHODS FOR MAKING AND USING THE SAME | Sanofi US Services Inc. (US) | 2025-04-09 | — | — | EP | disclosed |
| US-4293563-A | ANTIASTHMATICS | LILLY INDUSTRIES LIMITED (GB) | 1981-10-06 | — | — | US | disclosed |
| US-4241073-A | ASTHMA | LILLY INDUSTRIES LIMITED (GB) | 1980-12-23 | — | — | US | disclosed |
| EP-0005647-A1 | Hydantoin compounds, their preparation and pharmaceutical formulations containing them | Lilly Industries Limited (GB) | 1979-11-28 | — | — | EP | disclosed |
| US-4016037-A | FERMENTING A HYDANTOIN COMPOUND WITH FLAVOBACTERIUM AMINOGENES OR ITS ENZYMES | AJINOMOTO CO., INC. (JA) | 1977-04-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200281881-A1 | Alpha Keto Acid Compositions for Treating Hypo-Albuminemia | ALB, AADAT, BCAT2 | DDB1 4731/4885CRBN 2096/4885EPHX2 3821/4885 |
| US-20250228865-A1 | COMPOUNDS FOR ENHANCING READ THROUGH OF GENES CONTAINING PREMATURE TERMINATION CODONS AND METHODS FOR MAKING AND USING THE SAME | UPF1, NUDT21, RNGTT | DDB1 773/4885CRBN 1442/4885EPHX2 2855/4885 |
| US-20080241896-A1 | PROCESS FOR PRODUCTION OF OPTICALLY ACTIVE HYDROXYMETHYL-SUBSTITUTED PHENYLALANINE | PAH, HPD, DAO | DDB1 3013/4885CRBN 3314/4885EPHX2 404/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.